» Journals » J Immunopharmacol

Journal of Immunopharmacology

Journal of Immunopharmacology is a scientific journal, published since 1978 in English. The journal's country of origin is United States and its primary focus areas are pharmacology and allergy & immunology.

Details
Abbr. J Immunopharmacol
Start 1978
End 1986
Frequency Quarterly
p-ISSN 0163-0571
Country United States
Language English
Recent Articles
1.
Takeda T, Kobayashi T, Shimano T, Sekimoto M, Matsuura N, Kokunai I, et al.
J Immunopharmacol . 1986 Jan; 8(4):499-513. PMID: 3805745
Stable activated macrophage hybridomas were generated by somatic cell fusion between Propionibacterium acnes-induced peritoneal exudate cells and NS-1 myeloma cells. Five cell lines were obtained and each was cloned by...
2.
Kusnierczyk H, RADZIKOWSKI C, Paprocka M, Budzynski W, Rak J, Kinas R, et al.
J Immunopharmacol . 1986 Jan; 8(4):455-80. PMID: 3805744
The relationship between enantiomeric homogeneity of three oxazaphosphorine drugs: cyclophosphamide, ifosfamide and trofosfamide and their antitumor activity was evaluated by standard screening tests against four in vivo transplantable tumor models:...
3.
Patchen M, MacVittie T
J Immunopharmacol . 1986 Jan; 8(3):407-25. PMID: 3760593
A soluble form of the reticuloendothelial- and immune modulating agent glucan (glucan-F) has been evaluated for its effects on hemopoiesis. A single 5.0 mg intravenous injection of glucan-F into C3H/HeN...
4.
Kiesel U, Maruta K, Treichel U, Bicker U, Kolb H
J Immunopharmacol . 1986 Jan; 8(3):393-406. PMID: 3760592
BB rats spontaneously develop an insulin dependent diabetes which resembles in many features human type I diabetes. We have tested the effect of the immunomodulatory drug Ciamexone, a 2-cyan-aziridine-derivative, on...
5.
Nikcevich D, Young M, Ellis N, Newby M, Wepsic H
J Immunopharmacol . 1986 Jan; 8(3):299-313. PMID: 3760591
Indomethacin (IN) was administered to untreated or to cyclophosphamide (CY) treated C57B1/6 mice to study the roles of prostaglandins in regulating hematopoiesis. The following hematopoietic parameters were quantitated: peripheral blood...
6.
Watanabe N, Niitsu Y, Sone H, Neda H, URUSHIZAKI I, Yamamoto A, et al.
J Immunopharmacol . 1986 Jan; 8(2):271-83. PMID: 3722836
The therapeutic effect of endogenous tumor necrosis factor (TNF) on Meth A ascites fibrosarcoma in mice was investigated. Serum and peritoneal fluid from tumor bearing mice treated with OK-432 and...
7.
Luebke R, Riddle M, Rogers R, Rowe D, GARNER R, Smialowicz R
J Immunopharmacol . 1986 Jan; 8(2):243-57. PMID: 3722835
Administration of urethan (URE or ethyl carbamate) to mice results in the development of a variety of tumors, and, in certain strains of mice, marked suppression of the immune response....
8.
Reynolds M, McCann S
J Immunopharmacol . 1986 Jan; 8(1):99-116. PMID: 3711676
The effect of multiple sublethal doses of busulfan on the haemopoietic system of the Balb/c mouse was examined. FBC's bone marrow histology and bone marrow progenitor cell assays (CFU-E, BFU-E,...
9.
Flick D, Gifford G
J Immunopharmacol . 1986 Jan; 8(1):89-97. PMID: 3711675
The in vivo administration of tumor necrosis factor (TNF) provides a new approach to the immunotherapeutic treatment of tumors. We evaluated the pharmacokinetics of murine tumor necrosis factor in mice...
10.
Takano S, Sami S, Majima T, Ishida N
J Immunopharmacol . 1986 Jan; 8(1):59-73. PMID: 3711674
The low molecular weight fraction (mol wt less than 1,000) of Ehrlich cancer ascitic fluid has been known to enhance Listeria infection in mice. Chemical characterization of the entities in...